BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7448337)

  • 1. Analysis of allopurinol and oxypurinol in plasma and its application to metabolic studies.
    Sved S; Wilson DL
    Biopharm Drug Dispos; 1980; 1(3):111-7. PubMed ID: 7448337
    [No Abstract]   [Full Text] [Related]  

  • 2. [The clinical pharmacokinetics of allopurinol. 2. Allopurinol/oxypurinol pharmacokinetics following allopurinol in single doses and multiple application].
    Fenner H; Schiemann O; Gikalov I
    Arzneimittelforschung; 1985; 35(7):1093-6. PubMed ID: 4052144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of allopurinol and oxipurinol in biological fluids by high-performance liquid chromatography.
    Breithaupt H; Goebel G
    J Chromatogr; 1981 Nov; 226(1):237-42. PubMed ID: 7320148
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacokinetic studies on plasma elimination half-life of oxipurinol (author's transl)].
    Lach HJ; Bader B; Schnitker J; Harries EH
    Arzneimittelforschung; 1982; 32(1):76-9. PubMed ID: 7199345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-performance liquid chromatographic assay for allopurinol and oxipurinol in human plasma.
    Kramer WG; Feldman S
    J Chromatogr; 1979 Jan; 162(1):94-7. PubMed ID: 762214
    [No Abstract]   [Full Text] [Related]  

  • 6. [High pressure liquid chromatographic determination of allopurinol and oxipurinol in serum].
    Endele R; Lettenbauer G
    J Chromatogr; 1975 Dec; 115(1):228-31. PubMed ID: 1202065
    [No Abstract]   [Full Text] [Related]  

  • 7. Simultaneous determination of allopurinol and oxipurinol in biological fluids by mass fragmentography.
    Lartigue-Mattei C; Chabard JL; Bargnoux H; Petit J; Berger JA
    J Chromatogr; 1982 Apr; 229(1):211-6. PubMed ID: 7085828
    [No Abstract]   [Full Text] [Related]  

  • 8. [A new and quick method for determination of allopurinol and oxipurinol in serum (author's transl)].
    Nitsche V; Mascher H
    Arzneimittelforschung; 1980; 30(11):1855-7. PubMed ID: 7192993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma oxypurinol concentration in a patient with allopurinol hypersensitivity.
    Puig JG; Casas EA; Ramos TH; Michán AA; Mateos FA
    J Rheumatol; 1989 Jun; 16(6):842-4. PubMed ID: 2528636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of dietary protein on the clearance of allopurinol and oxypurinol.
    Berlinger WG; Park GD; Spector R
    N Engl J Med; 1985 Sep; 313(13):771-6. PubMed ID: 4033706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The allopurinol hypersensitivity syndrome: its relation to plasma oxypurinol levels.
    Casas E; Puig JG; Mateos FA; Jiménez ML; Michán AD; Ramos TH
    Adv Exp Med Biol; 1989; 253A():257-60. PubMed ID: 2624201
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantitative liquid chromatography of allopurinol and oxypurinol in human plasma and urine.
    Failler JM; Farinotti R; Dauphin A
    Ther Drug Monit; 1985; 7(3):324-8. PubMed ID: 4049473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacokinetics or oral and intravenous allopurinol and intravenous oxypurinol in the horse.
    Mills PC; Dunnett M; Smith NC
    J Vet Pharmacol Ther; 1995 Dec; 18(6):451-6. PubMed ID: 8789699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Time course of oxipurinol levels in plasma following single dose and chronic administration of allopurinol in different pharmaceutical preparations (author's transl)].
    Walter-Sack I; Gröbner W; Zöllner N
    Arzneimittelforschung; 1979; 29(5):839-42. PubMed ID: 582985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxypurinol, allopurinol and allopurinol-1-riboside in plasma following an acute overdose of allopurinol in a patient with advanced chronic kidney disease.
    Kannangara DR; Roberts DM; Furlong TJ; Graham GG; Williams KM; Day RO
    Br J Clin Pharmacol; 2012 May; 73(5):828-9. PubMed ID: 22098112
    [No Abstract]   [Full Text] [Related]  

  • 16. Allopurinol-induced suppressor T cell dysfunction.
    Elion GB; Williams TE
    J Am Acad Dermatol; 1982 Nov; 7(5):687-8. PubMed ID: 6216274
    [No Abstract]   [Full Text] [Related]  

  • 17. The influence of allopurinol in customary and in slow release preparation on different parameters of purine and pyrimidine metabolism.
    Gröbner W; Walter I; Rauch-Janssen A; Zöllner N
    Adv Exp Med Biol; 1977; 76B():297-303. PubMed ID: 855755
    [No Abstract]   [Full Text] [Related]  

  • 18. Simultaneous liquid chromatography of 5-fluorouracil, uridine, hypoxanthine, xanthine, uric acid, allopurinol, and oxipurinol in plasma.
    Wung WE; Howell SB
    Clin Chem; 1980 Nov; 26(12):1704-8. PubMed ID: 7428153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The determination of allopurinol and oxipurinol in human plasma and urine.
    Brown M; Bye A
    J Chromatogr; 1977 Mar; 143(2):195-202. PubMed ID: 838831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facile and rapid high-performance liquid chromatography method for simultaneous determination of allopurinol and oxypurinol in human serum.
    Tada H; Fujisaki A; Itoh K; Suzuki T
    J Clin Pharm Ther; 2003 Jun; 28(3):229-34. PubMed ID: 12795781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.